Abstract:The crosstalk between tumor cells and macrophages under hypoxic conditions has been acknowledged as a pivotal determinant in the progression of colorectal cancer (CRC). Previous research has underscored the significance of exosomes derived from hypoxic tumor cells in facilitating tumor progression through inducing the polarization of macrophages towards the M2-like phenotype. The precise influence of hypoxic macrophage-derived exosomes (HMDEs) on the progression of CRC has not yet been fully elucidated. The objective of this study was to investigate the role of HMDEs in the progression of CRC. We discovered that there was an elevated release of exosomes derived from macrophages in hypoxic conditions. Additionally, the hypoxia-induced macrophage-derived exosomes played a crucial role in promoting the progression of CRC. We have also demonstrated that HMDEs have the ability to induce cell cycle transition and inhibit cell apoptosis, thereby promoting the growth of CRC cells. Furthermore, the underlying molecular mechanisms of these effects have been identified. The overexpression of Hif-1α results in its direct interaction with distinct regions (-521− -516 bp and -401− -391 bp) of the Hsp90 promoter during hypoxic circumstances. This binding event led to the overexpression of Hsp90 and the subsequent elevation of Hsp90 protein levels within HMDEs. Importantly, the crucial interaction between Hsp90 and Lats1 resulted in the deactivation of Lats1 and the inhibition of Yap phosphorylation. Ultimately, this series of events lead to the deactivation of the Hippo signaling pathway. Our in vivo and in vitro studies presented compelling evidence for the crucial role of hypoxic macrophage-derived exosomal Hsp90 in promoting CRC progression through the inhibition of the Hippo signaling pathway. These findings represented a significant advancement in our comprehension of the complex interplay between macrophages and CRC cells under hypoxic conditions.

Cytoskeleton-Centric Protein Transportation by Exosomes Transforms Tumor-Favorable Macrophages

Multifaceted roles of exosomes in epithelial-mesenchymal transition and tumor metastasis

Exosomes: A Potential Therapeutic Tool Targeting Communications Between Tumor Cells and Macrophages.

Exosome-Mediated Crosstalk Between Tumor and Tumor-Associated Macrophages

Exosome Mediated Multidrug Resistance in Cancer.

Macrophage-derived exosomes in cancers: Biogenesis, functions and therapeutic applications

Exosomes promote pre-metastatic niche formation in colorectal cancer

Unveiling the role of hypoxic macrophage-derived exosomes in driving colorectal cancer progression

Exosomes in metastasis of colorectal cancers: Friends or foes?

Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression

Exosomal ncRNAs facilitate interactive 'dialogue' between tumor cells and tumor-associated macrophages

Colorectal Cancer Exosomes Induce Lymphatic Network Remodeling in Lymph Nodes

An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments

Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components

Exosome-Derived Non-Coding RNAs in the Tumor Microenvironment of Colorectal Cancer: Possible Functions, Mechanisms and Clinical Applications

Exosomal MicroRNAs Mediating Crosstalk Between Cancer Cells With Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in the Tumor Microenvironment

Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment

Exosomes in the tumor microenvironment: Promoting cancer progression

Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer

Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis

Hypoxic Macrophage-derived Exosomes Mediate Colorectal Cancer Progression through Targeting the Hippo Signaling Pathway